Androgen receptor in bladder cancer: A promising therapeutic target
There has been a significant progress in the treatment of metastatic urothelial carcinoma in the last few years with the advent of immunotherapy after a long gap of no drug approvals for over 4 decades. While immunotherapy with checkpoint inhibitors has revolutionized the treatment of urothelial car...
שמור ב:
| Principais autores: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2020-07-01
|
| סדרה: | Asian Journal of Urology |
| נושאים: | |
| גישה מקוונת: | http://www.sciencedirect.com/science/article/pii/S2214388220300370 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|